Support our Foundation of Myology project
EFC17236-Sanofi Mobilize
A phase 3, double-blind, placebo-controlled study evaluating the efficacy and safety of riliprubart in participants with refractory chronic inflammatory demyelinating polyneuropathy.
Support our Foundation of Myology project
A phase 3, double-blind, placebo-controlled study evaluating the efficacy and safety of riliprubart in participants with refractory chronic inflammatory demyelinating polyneuropathy.